Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
71 hedge funds and large institutions have $280M invested in Oxford Immunotec Global PLC Ordinary Shares in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
9% more funds holding
Funds holding: 65 → 71 (+6)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
8% less capital invested
Capital invested by funds: $304M → $280M (-$24.4M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$4.75M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.92M |
| 3 |
TAM
Tocqueville Asset Management
New York
|
+$2.75M |
| 4 |
WIC
Water Island Capital
New York
|
+$1.99M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$2.88M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.7M |
| 4 |
Morgan Stanley
New York
|
-$1.39M |
| 5 |
JP Morgan Chase
New York
|
-$1.22M |
OXFD Hedge Fund Activity: Q3 2020 in Review
71 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2020, worth a combined $280M — down 8% from $304M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OXFD positions and 5 closed out — a net gain of 6 holders — while 22 added to existing stakes and 24 trimmed.
The largest buyer was Endurant Capital Management, adding an estimated $4.75M. The largest seller was Deerfield Management, cutting an estimated $2.88M.
- 71 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2020, up from 65 in Q2 2020.
- Funds reported $280M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2020, down 8% quarter-over-quarter.
- 11 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2020 and 5 closed out, a net change of +6 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2020 was Endurant Capital Management, an estimated $4.75M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2020 was Deerfield Management, an estimated $2.88M sold.
Based on aggregated 13F filings for Q3 2020.